Research Use Only — for laboratory research use, not for human consumption. Not evaluated by any regulatory authority.

Injection Pen

peptides

Retatrutide + Cagrilintide

Triple agonist + amylin analogue blend

Retatrutide + Cagrilintide, 99% purity, for laboratory research use. A research blend of a GLP-1/GIP/glucagon triple-agonist peptide and a long-acting amylin-analogue peptide, investigated in vitro for incretin- and amylin-receptor activity.

Peptide research blend (triple-agonist + amylin analogue)
≥ 99%+ purity (HPLC)
Store lyophilised at −20 °C, protect from light
Pre-filled injection pen

For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.

Certificate of Analysis (COA)

Amount

30 mg + 5 mg

Purity

99%+

Select size

Total

1,250 AED

CAS	2381089-83-2 / 1415456-99-3
Molecular mass	—
Molecular formula	—
Sequence	—
Form	Pre-filled injection pen
Purity	≥ 99%+
Storage	−20 °C, protect from light
COA	Available on request

Independently third-party tested · COA available on request.

Research Use Only

This product is intended for laboratory research use only. It is not a drug, food, or cosmetic, and is not intended for human or animal use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes.